SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001213900-19-009783
Filing Date
2019-05-30
Accepted
2019-05-30 11:52:16
Documents
2
Group Members
GRAND ASCENT GROUP LTDYIMEI ZHANG

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d0519wu_xynomicpharma.htm SC 13D 88585
2 JOINT FILING AGREEMENT, DATED MAY 29, 2019 sc13d0519wuex99-1_xynomic.htm EX-99.1 3586
  Complete submission text file 0001213900-19-009783.txt   93823
Mailing Address 609-610 21ST CENTURY TOWER 40 LIANGMAQIAO ROAD, CHAOYANG DISTRICT BEIJING F4 100016
Business Address 609-610 21ST CENTURY TOWER 40 LIANGMAQIAO ROAD, CHAOYANG DISTRICT BEIJING F4 100016 9493506999
XYNOMIC PHARMACEUTICALS HOLDINGS, INC. (Subject) CIK: 0001697805 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90028 | Film No.: 19865369
SIC: 2834 Pharmaceutical Preparations

Mailing Address SUITE 3306, K. WAH CENTRE 1010 MIDDLE HUAIHAI ROAD SHANGHAI F4 200031
Business Address
Wu Wentao Jason (Filed by) CIK: 0001774745 (see all company filings)

Type: SC 13D